Editor-in-Chief: Alaa Abd-Elsayed, MD, PhD
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is not only one of the most common adverse experiences of cancer survivors, but it is also one which has the greatest effect on quality of life. Ultimately, CIPN can lead to unwanted modification of treatment such as chemotherapy dose reductions or termination of treatment altogether.
CASE REPORT: We present a case of a 47-year-old man with severe bilateral CIPN resistant to conservative management, who was successfully treated with spinal cord stimulation.
CONCLUSION: Spinal cord stimulation can be an effective treatment for CIPN resistant to conservative management.
KEY WORDS: Spinal cord stimulator, chemotherapy induced neuropathy, peripheral neuropathy